Stroke-Related Outcomes in Moyamoya Disease Compared with Moyamoya Syndromes: A Propensity-Matched Analysis
Patients with MMS-SCD had significantly lower rates of acute ischemic stroke, hemorrhagic stroke, and TIA compared with patients with MMD only. Future research should consider the source of these differences in improving stroke prevention in patients with MMD.
Authors
- Christopher S. Ogilvy (ORCID: https://orcid.org/0000-0003-4600-8545)
- Felipe Ramirez‐Velandia (ORCID: https://orcid.org/0000-0003-1041-6360)
- Coleman P. Riordan (ORCID: https://orcid.org/0000-0001-5073-3606)
- Alejandro Enríquez-Marulanda (ORCID: https://orcid.org/0000-0001-6091-390X)
- Philipp Taussky (ORCID: https://orcid.org/0000-0001-9247-0146)
- Justin H. Granstein (ORCID: https://orcid.org/0000-0002-4748-2073)
- Kimberly Han (ORCID: https://orcid.org/0000-0001-9118-501X)
- Omar Alwakaa (ORCID: https://orcid.org/0009-0008-6441-5420)
- Aryan Wadhwa (ORCID: https://orcid.org/0009-0007-0051-895X)
- Evan McNeil (ORCID: https://orcid.org/0000-0002-2015-6681)
Institutions
- Beth Israel Deaconess Medical Center (US)
Publication Details
- Journal
- World Neurosurgery
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1016/j.wneu.2024.11.104
- Citations
- 6
- Primary Topic
- Moyamoya disease diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.82